caffeine has been researched along with dipyridamole in 61 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (31.15) | 18.7374 |
| 1990's | 14 (22.95) | 18.2507 |
| 2000's | 14 (22.95) | 29.6817 |
| 2010's | 13 (21.31) | 24.3611 |
| 2020's | 1 (1.64) | 2.80 |
| Authors | Studies |
|---|---|
| Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF | 1 |
| Bonta, IL; Vincent, JE; Zijlstra, FJ | 1 |
| Asano, T; Hidaka, H; Ochiai, Y | 1 |
| Diamantopoulos, G; Goerttler, U; Juchelka, W; Matthes, D; Roth, FJ; Schmier, J; Wenz, W | 1 |
| Nasir, T; Zarrindast, MR | 1 |
| Mitsumoto, Y; Mohri, T; Ohkubo, T | 1 |
| Aengevaeren, WR; Corstens, FH; Smits, P; Thien, T; Wackers, FJ | 1 |
| Pijpers, E; Smits, P; Straatman, C; Thien, T | 1 |
| Mante, S; Minneman, KP | 1 |
| Raybin, D | 1 |
| Barraco, RA; DeLong, RE; Phillis, JW; Washington, DO | 1 |
| Daly, JW; Deckert, J; Jacobson, KA; Marangos, PJ; Morgan, PF | 1 |
| Aengevaeren, WR; Corstens, FH; Smits, P; Thien, T | 1 |
| DeLong, RE; Phillis, JW | 1 |
| Henry, JL; Salter, MW | 1 |
| Byon, KY; Fleckenstein, A | 1 |
| Mills, DC; Smith, JB | 1 |
| Brock, N; Pohl, VP | 1 |
| Nitz, RE; Scholtholt, J; Schraven, E | 1 |
| Panceri, P; Villa, RF | 1 |
| Gordon, JL | 1 |
| Dhalla, NS; Heyliger, CE; Panagia, V | 1 |
| Pedata, F; Pepeu, G; Spignoli, G | 1 |
| DeLong, RE; Phillis, JW; Preston, G | 1 |
| Harfenist, EJ; Kinlough-Rathbone, RL; Mustard, JF; Packham, MA | 1 |
| Böttcher, M; Czernin, J; Phelps, ME; Schelbert, HR; Sun, KT | 1 |
| Charland, SL; Melko, GP; Stanek, EJ | 1 |
| Liu, C; Zhao, F; Zhu, L | 1 |
| Shafaghi, B; Zarrindast, MR | 1 |
| Cerqueira, MD; Jacobson, AF; Raisys, V; Shattuc, S | 1 |
| Aranda, JV; Davis, GM; Lopes, JM; Mullahoo, K | 1 |
| Eigler, A; Endres, S; Greten, TF; Haslberger, C; Sinha, B; Sullivan, GW | 1 |
| Hurwitz, R; Lyons, K; Taketa, R | 1 |
| Capasso, A | 1 |
| Materi, LM; Rasmusson, DD; Semba, K | 1 |
| De Galan, BE; Keijzers, GB; Smits, P; Tack, CJ | 1 |
| Williams, RC; Zheng, XM | 1 |
| Costentin, J; El Yacoubi, M; Ledent, C; Parmentier, M; Vaugeois, JM | 1 |
| Kitano, H; Konishi, J; Kubo, S; Magata, Y; Mamede, M; Mukai, T; Tadamura, E; Tamaki, N; Toyoda, H; Yamamuro, M | 1 |
| Boerman, OC; Engbersen, R; Oyen, WJ; Ramakers, BP; Riksen, NP; Rongen, GA; Smits, P; Van den Broek, PH | 1 |
| Meijer, P; Riksen, NP; Rongen, GA; Scheffer, GJ; Smits, P; van den Broek, PH; Wouters, CW | 1 |
| Binfaré, RW; Budni, J; Lobato, KR; Rodrigues, AL; Rosa, AO; Santos, AR | 1 |
| Boerman, OC; Dekker, D; Meijer, P; Oyen, WJ; Rongen, GA; Scheffer, GJ; Smits, P; van den Broek, PH; Wouters, CW | 1 |
| Capasso, A; Gallo, C | 1 |
| Kern, MJ; Salcedo, J | 1 |
| Banko, LT; Fogel, J; Haq, SA; Heitner, JF; Klem, I; Rainaldi, DA; Sacchi, TJ; Siegler, J | 1 |
| Dutchak, P; Matangi, M | 1 |
| Bilos, A; Deinum, J; Donders, AR; Riksen, NP; Rongen, GA; van den Berg, TN | 1 |
| Aronsen, L; Lysaa, R; Orvoll, E; Ravna, AW; Sager, G | 1 |
| Buttar, HS; Kaur, T; Mohey, V; Pathak, D; Puri, N; Singh, AP; Singh, M | 1 |
| Babar, AK; Bui, L; DeGolovine, A; Gould, KL; Johnson, NP; Kitkungvan, D; Kumar, S; Madjid, M; Nacimbene, A; Patel, MB; Roby, AE; Vejpongsa, P | 1 |
4 review(s) available for caffeine and dipyridamole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells | 2022 |
Xanthine interference with dipyridamole-thallium-201 myocardial imaging.
Topics: Adenosine; Animals; Caffeine; Coronary Disease; Dipyridamole; Dogs; False Negative Reactions; Heart; Humans; Male; Pentoxifylline; Radionuclide Imaging; Thallium Radioisotopes; Xanthine; Xanthines | 1995 |
Effects of caffeine and theophylline on coronary hyperemia induced by adenosine or dipyridamole.
Topics: Adenosine; Animals; Caffeine; Coronary Circulation; Coronary Disease; Dipyridamole; Drug Administration Schedule; Drug Interactions; Echocardiography, Doppler; Humans; Hyperemia; Myocardial Perfusion Imaging; Positron-Emission Tomography; Practice Guidelines as Topic; Predictive Value of Tests; Theophylline; Time Factors; Vasodilator Agents | 2009 |
10 trial(s) available for caffeine and dipyridamole
| Article | Year |
|---|---|
Dose-dependent inhibition of the hemodynamic response to dipyridamole by caffeine.
Topics: Adult; Blood Pressure; Caffeine; Dipyridamole; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Infusions, Intravenous; Male; Random Allocation | 1991 |
Adenosine challenge and boost protocols: new tools for myocardial perfusion imaging.
Topics: Adenosine; Caffeine; Cardiac Output; Coronary Disease; Dipyridamole; Exercise Test; Heart; Humans; Radionuclide Imaging | 1999 |
Caffeine can decrease insulin sensitivity in humans.
Topics: Adult; Caffeine; Central Nervous System Stimulants; Dipyridamole; Double-Blind Method; Epinephrine; Female; Glucose Clamp Technique; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Male; Norepinephrine; Phosphodiesterase Inhibitors | 2002 |
Serum caffeine levels after 24-hour abstention: clinical implications on dipyridamole (201)Tl myocardial perfusion imaging.
Topics: Aged; Blood Pressure; Caffeine; Central Nervous System Stimulants; Dipyridamole; Exercise Test; False Negative Reactions; Female; Heart; Heart Rate; Humans; Male; Radionuclide Imaging; Reproducibility of Results; Sensitivity and Specificity; Thallium; Vasodilator Agents | 2002 |
Dipyridamole enhances ischaemia-induced reactive hyperaemia by increased adenosine receptor stimulation.
Topics: Adult; Caffeine; Central Nervous System Stimulants; Dipyridamole; Female; Forearm; Humans; Hyperemia; Ischemia; Male; Receptor, Adenosine A1; Receptors, Adenosine A2; Regional Blood Flow; Time Factors; Vasodilator Agents | 2008 |
Rosuvastatin increases extracellular adenosine formation in humans in vivo: a new perspective on cardiovascular protection.
Topics: Adenosine; Administration, Oral; Annexin A5; Caffeine; Dipyridamole; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluorobenzenes; Forearm; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infusions, Intra-Arterial; Male; Nitroprusside; Pyrimidines; Radionuclide Imaging; Regional Blood Flow; Reperfusion Injury; Rosuvastatin Calcium; Sulfonamides; Time Factors; Up-Regulation; Vasodilation; Vasodilator Agents | 2009 |
Incidence of caffeine in serum of patients undergoing dipyridamole myocardial perfusion stress test by an intensive versus routine caffeine history screening.
Topics: Aged; Caffeine; Coronary Disease; Dipyridamole; Drug Interactions; Exercise Test; Female; Hemodynamics; Humans; Incidence; Male; Mass Screening; Medical History Taking; Middle Aged; Multivariate Analysis; Myocardial Infarction; Myocardial Perfusion Imaging; Prospective Studies; Reference Values; Regression Analysis; Risk Factors; Sensitivity and Specificity; Vasodilator Agents | 2010 |
Buccal caffeine for the routine reversal of Persantine.
Topics: Administration, Buccal; Aged; Caffeine; Coronary Artery Disease; Dipyridamole; Exercise Test; Female; Humans; Male; Myocardial Perfusion Imaging; Vasodilator Agents | 2014 |
The effect of eplerenone on adenosine formation in humans in vivo: a double-blinded randomised controlled study.
Topics: Adenosine; Caffeine; Dipyridamole; Double-Blind Method; Eplerenone; Forearm; Hemodynamics; Humans; Hyperemia; Male; Nitroprusside; Regional Blood Flow; Spironolactone; Treatment Outcome; Young Adult | 2014 |
Quantitative myocardial perfusion positron emission tomography and caffeine revisited with new insights on major adverse cardiovascular events and coronary flow capacity.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Aged; Caffeine; Cardiovascular Diseases; Coronary Circulation; Dipyridamole; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Positron-Emission Tomography; Purines; Pyrazoles | 2019 |
47 other study(ies) available for caffeine and dipyridamole
| Article | Year |
|---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The effect of non-steroid anti-inflammatory drugs, dibutyryl cyclic 3',5'-adenosine monophosphate and phosphodiesterase inhibitors on platelet aggregation and the platelet release reaction in normal and essential fatty acid deficient rats.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Bucladesine; Caffeine; Depression, Chemical; Dipyridamole; Fatty Acids, Essential; Indomethacin; Papaverine; Phosphodiesterase Inhibitors; Platelet Aggregation; Rats | 1975 |
Selective inhibition of separated forms of human platelet cyclic nucleotide phosphodiesterase by platelet aggregation inhibitors.
Topics: Adenosine; Blood Platelets; Caffeine; Chromatography, DEAE-Cellulose; Cyclic AMP; Cyclic GMP; Depression, Chemical; Dipyridamole; Humans; In Vitro Techniques; Kinetics; Papaverine; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Phthalazines; Platelet Aggregation; Theophylline | 1977 |
[Coronary-angiographic demonstration of the dilating effect of dipyridamole on coronary arteries and its inhibition by caffeine (author's transl)].
Topics: Angiocardiography; Animals; Blood Pressure; Caffeine; Cineangiography; Coronary Angiography; Coronary Circulation; Coronary Vessels; Diatrizoate; Dipyridamole; Dogs; Dose-Response Relationship, Drug; Female; Male; Time Factors | 1975 |
Methylxanthine-induced attenuation of pecking in chickens.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Apomorphine; Behavior, Animal; Caffeine; Chickens; Dipyridamole; Female; Male; Theophylline; Xanthines | 1991 |
Characterization of the uptake of adenosine by cultured rat hippocampal cells and inhibition of the uptake by xanthine derivatives.
Topics: 2-Chloroadenosine; Adenosine; Affinity Labels; Animals; Biological Transport; Caffeine; Cells, Cultured; Cytarabine; Dipyridamole; Embryo, Mammalian; Hippocampus; Kinetics; Neuroglia; Neurons; Pentoxifylline; Rats; Sodium; Theophylline; Thioinosine; Tritium; Xanthines | 1991 |
False-negative dipyridamole-thallium-201 myocardial imaging after caffeine infusion.
Topics: Caffeine; Coronary Disease; Dipyridamole; False Negative Reactions; Female; Heart; Hemodynamics; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Predictive Value of Tests; Radionuclide Imaging; Thallium Radioisotopes | 1991 |
Is adenosine involved in inhibition of forskolin-stimulated cyclic AMP accumulation by caffeine in rat brain?
Topics: Adenosine; Adenosine Deaminase; Animals; Brain Chemistry; Caffeine; Cerebral Cortex; Colforsin; Cyclic AMP; Dipyridamole; Drug Synergism; In Vitro Techniques; Male; Phosphodiesterase Inhibitors; Potassium Chloride; Rats; Rats, Inbred Strains; Receptors, Purinergic | 1990 |
Caffeine and methylxanthines.
Topics: Caffeine; Dipyridamole; Drug Interactions; Humans; Theophylline | 1990 |
Behavioral characteristics of centrally administered adenosine analogs.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine; Adenosine Deaminase Inhibitors; Animals; Caffeine; Dilazep; Dipyridamole; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Motor Activity | 1986 |
Potent convulsant actions of the adenosine receptor antagonist, xanthine amine congener (XAC).
Topics: Animals; Caffeine; Convulsants; Diazepam; Dipyridamole; Male; Mice; Purinergic Antagonists; Random Allocation; Seizures; Theophylline; Xanthines | 1989 |
Caffeine reduces dipyridamole-induced myocardial ischemia.
Topics: Caffeine; Coronary Disease; Dipyridamole; Electrocardiography; Heart; Humans; Male; Middle Aged; Radionuclide Imaging; Thallium Radioisotopes | 1989 |
An involvement of adenosine in cerebral blood flow regulation during hypercapnia.
Topics: Adenosine; Animals; Blood Pressure; Caffeine; Cerebrovascular Circulation; Coformycin; Dipyridamole; Hypercapnia; Male; Pentostatin; Rats; Rats, Inbred Strains | 1987 |
Evidence that adenosine mediates the depression of spinal dorsal horn neurons induced by peripheral vibration in the cat.
Topics: Adenosine; Animals; Bicuculline; Blood Pressure; Caffeine; Cats; Dipyridamole; Injections, Intravenous; Iontophoresis; Naloxone; Neurons; Spinal Cord; Strychnine; Theophylline; Vibration | 1987 |
Proceedings: Prevention by Ca-antagonistic compounds (verapamil, D 600) of coronary smooth muscle contractures due to treatment with cardiac glycosides.
Topics: Animals; Caffeine; Calcium; Cardiac Glycosides; Coronary Vessels; Dipyridamole; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; Prenylamine; Theophylline; Verapamil | 1974 |
Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase.
Topics: Animals; Blood Platelets; Brain; Caffeine; Cattle; Cyclic AMP; Dipyridamole | 1970 |
[Comparative investigation on the vitro inhibition of adenosine decomposition by dilazep].
Topics: Adenosine; Adult; Azepines; Benzoates; Caffeine; Cell Membrane Permeability; Dipyridamole; Drug Interactions; Erythrocytes; Ethylenediamines; Humans; In Vitro Techniques; Lidoflazine; Theophylline; Vasodilator Agents | 1974 |
On the mechanism of the antagonistic action of xanthine derivatives against adenosine and coronary vasodilators.
Topics: Acetamides; Adenosine; Animals; Blood Flow Velocity; Caffeine; Cell Membrane Permeability; Coronary Vessels; Coumarins; Dipyridamole; Dogs; Drug Interactions; Erythrocytes; Female; Glycolates; Humans; Male; Piperazines; Receptors, Drug; Structure-Activity Relationship; Theophylline; Vasodilator Agents; Xanthines; Xylenes | 1972 |
Action of some drugs on performance time in mice.
Topics: Animals; Behavior, Animal; Brain; Caffeine; Dipyridamole; Energy Transfer; Ergolines; Male; Mice; Physical Exertion | 1973 |
Differential changes in potency of platelet-aggregation inhibitors after preincubation in platelet-rich plasma.
Topics: Adenosine Diphosphate; Amitriptyline; Animals; Caffeine; Chlorpromazine; Diphenhydramine; Dipyridamole; Imipramine; Papaverine; Plasma; Platelet Adhesiveness; Swine; Time Factors; Trifluoperazine | 1974 |
Effect of cyclic AMP phosphodiesterase inhibitors on cardiac sarcolemmal 5'-nucleotidase.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 5'-Nucleotidase; Animals; Caffeine; Dipyridamole; In Vitro Techniques; Male; Myocardium; Nucleotidases; Papaverine; Rats; Sarcolemma; Theophylline | 1981 |
Biphasic effect of methylxanthines on acetylcholine release from electrically-stimulated brain slices.
Topics: Acetylcholine; Adenosine; Aminophylline; Animals; Brain; Caffeine; Dipyridamole; Drug Interactions; Electric Stimulation; In Vitro Techniques; Male; Rats; Rats, Inbred Strains; Xanthines | 1984 |
Effects of anoxia on cerebral blood flow in the rat brain: evidence for a role of adenosine in autoregulation.
Topics: Adenosine; Animals; Brain; Caffeine; Cerebrovascular Circulation; Dipyridamole; Homeostasis; Hypoxia; Injections, Intravenous; Male; Papaverine; Rats; Rats, Inbred Strains; Regional Blood Flow | 1984 |
Inhibitors of ADP-induced platelet aggregation prevent fibrinogen binding to rabbit platelets and cause rapid deaggregation and dissociation of bound fibrinogen.
Topics: Adenosine Diphosphate; Animals; Binding Sites; Blood Platelets; Caffeine; Colchicine; Cytochalasin B; Dipyridamole; Edetic Acid; Egtazic Acid; Epoprostenol; Fibrinogen; Humans; Platelet Aggregation; Prostaglandins E; Rabbits | 1981 |
Effect of caffeine on myocardial blood flow at rest and during pharmacological vasodilation.
Topics: Adult; Ammonia; Caffeine; Central Nervous System Stimulants; Coronary Circulation; Coronary Disease; Coronary Vessels; Dipyridamole; Dose-Response Relationship, Drug; Female; Heart; Hemodynamics; Humans; Male; Nitrogen Radioisotopes; Tomography, Emission-Computed; Vasodilator Agents | 1995 |
[Involvement of purines in analgesia produced by weak electro-acupuncture].
Topics: Acupuncture Analgesia; Animals; Caffeine; Dipyridamole; Electroacupuncture; Pain Threshold; Purinergic P1 Receptor Antagonists; Rats; Spinal Cord; Theophylline | 1994 |
Effects of adenosine receptor agonists and antagonists on acquisition of passive avoidance learning.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Analysis of Variance; Animals; Avoidance Learning; Caffeine; Dipyridamole; Dose-Response Relationship, Drug; Drug Interactions; Injections, Intraperitoneal; Male; Mice; Phenylisopropyladenosine; Purinergic P1 Receptor Antagonists; Theophylline; Vasodilator Agents | 1994 |
Serum caffeine levels after 24 hours of caffeine abstention: observations on clinical patients undergoing myocardial perfusion imaging with dipyridamole or adenosine.
Topics: Adenosine; Caffeine; Contraindications; Coronary Disease; Dipyridamole; Heart; Hemodynamics; Humans; Immunoenzyme Techniques; Male; Middle Aged; Thallium Radioisotopes; Time Factors; Tomography, Emission-Computed, Single-Photon | 1994 |
Role of adenosine in the hypoxic ventilatory response of the newborn piglet.
Topics: Adenosine; Animals; Animals, Newborn; Caffeine; Cerebrospinal Fluid; Citrates; Dipyridamole; Drug Combinations; Hypoxia; Oxygen; Purinergic P1 Receptor Antagonists; Respiration; Swine; Theophylline | 1994 |
Endogenous adenosine curtails lipopolysaccharide-stimulated tumour necrosis factor synthesis.
Topics: Adenosine; Adenosine Deaminase; Caffeine; Dipyridamole; Humans; Inosine; Leukocytes, Mononuclear; Lipopolysaccharides; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Antagonists; Pyrrolidinones; Rolipram; Tumor Necrosis Factor-alpha; Xanthines | 1997 |
Adenosine receptors are involved in the control of acute naloxone-precipitated withdrawal: in vitro evidence.
Topics: Adenosine; Animals; Caffeine; Dipyridamole; Guinea Pigs; Ileum; In Vitro Techniques; Male; Naloxone; Narcotic Antagonists; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Substance Withdrawal Syndrome; Theobromine; Theophylline | 2000 |
Inhibition of synaptically evoked cortical acetylcholine release by adenosine: an in vivo microdialysis study in the rat.
Topics: Acetylcholine; Adenosine; Analysis of Variance; Animals; Caffeine; Cerebral Cortex; Chromatography, High Pressure Liquid; Dipyridamole; Male; Microdialysis; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Synapses; Xanthines | 2000 |
Caffeine reduces hypnotic effects of alcohol through adenosine A2A receptor blockade.
Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Body Temperature; Caffeine; Central Nervous System Depressants; Central Nervous System Stimulants; Dipyridamole; Drug Overdose; Ethanol; Hypnotics and Sedatives; Male; Mice; Mice, Knockout; Neuroprotective Agents; Pentobarbital; Postural Balance; Pyrimidines; Receptor, Adenosine A2A; Triazoles; Vasodilator Agents; Xanthines | 2003 |
Effect of caffeine intake on myocardial hyperemic flow induced by adenosine triphosphate and dipyridamole.
Topics: Adenosine Triphosphate; Adult; Caffeine; Coronary Circulation; Dipyridamole; Heart; Hemodynamics; Humans; Hyperemia; Infusions, Intravenous; Male; Oxygen Radioisotopes; Tomography, Emission-Computed; Vasodilator Agents; Water | 2004 |
Oral therapy with dipyridamole limits ischemia-reperfusion injury in humans.
Topics: Administration, Oral; Adult; Annexin A5; Blood Pressure; Caffeine; Dipyridamole; Drug Administration Schedule; Exercise; Exercise Tolerance; Forearm; Heart Rate; Humans; Ischemic Preconditioning; Male; Muscle, Skeletal; Radionuclide Imaging; Reperfusion Injury; Technetium; Uridine | 2005 |
Involvement of the adenosine A1 and A2A receptors in the antidepressant-like effect of zinc in the forced swimming test.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Agonists; Aniline Compounds; Animals; Antidepressive Agents; Caffeine; Central Nervous System Stimulants; Dipyridamole; Female; Male; Mice; Motor Activity; Nucleoside Transport Proteins; Receptor, Adenosine A1; Receptor, Adenosine A2A; Swimming; Triazines; Triazoles; Xanthines; Zinc | 2008 |
Functional interaction between purinergic system and opioid withdrawal: in vitro evidence.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenosine Triphosphate; Analgesics, Opioid; Animals; Caffeine; Dipyridamole; Dose-Response Relationship, Drug; Guinea Pigs; Ileum; In Vitro Techniques; Male; Morphine; Morphine Dependence; Muscle, Smooth; Naloxone; Narcotic Antagonists; Narcotics; Phenethylamines; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Quinidine; Receptor, Adenosine A1; Receptors, Adenosine A2; Receptors, Purinergic P2; Substance Withdrawal Syndrome; Theobromine; Theophylline | 2009 |
Modulation of high affinity ATP-dependent cyclic nucleotide transporters by specific and non-specific cyclic nucleotide phosphodiesterase inhibitors.
Topics: ATP-Binding Cassette Transporters; Caffeine; Carbolines; Cyclic AMP; Cyclic GMP; Dipyridamole; Humans; Imidazoles; Kinetics; Multidrug Resistance-Associated Proteins; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Purinones; Sulfones; Tadalafil; Theophylline; Triazines; Vardenafil Dihydrochloride | 2014 |
Dipyridamole attenuates ischemia reperfusion induced acute kidney injury through adenosinergic A1 and A2A receptor agonism in rats.
Topics: Acute Kidney Injury; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Biomarkers; Caffeine; Cytoprotection; Dipyridamole; Disease Models, Animal; Kidney; Male; Oxidative Stress; Rats, Wistar; Receptor, Adenosine A1; Receptor, Adenosine A2A; Reperfusion Injury; Signal Transduction | 2016 |